C07C 69 - Esters of carboxylic acids; Esters of carbonic or haloformic acids

Patents for C07C 69 - Esters of carboxylic acids; Esters of carbonic or haloformic acids (54,756)
11/2009
11/11/2009	CN100558351C Compounds and methods for delivery of prostacyclin analogs
11/10/2009	US7615658 Comprising mixture of formyl-substituted fatty acids or fatty acid esters comprising in terms of formyl distribution from greater than 10 to less than 95 percent monoformyl; can be hydrogenated using organophosphine catalyst to corresponding alcohol for preparation of polyols for polyurethane foams
11/10/2009	US7615576 Prevention of neutrophil recruitment
11/10/2009	US7615575 Compounds for the treatment of metabolic disorders
11/10/2009	US7615546 Topical delivery system for phytosterols
11/10/2009	CA2376522C A process for improving the stability and/or preventing the deactivation of the catalyst during the manufacture of acetic acid and/or of methyl acetate
11/10/2009	CA2372763C New process
11/10/2009	CA2341555C Process for the production of acetic acid
11/10/2009	CA2320244C Method for producing aqueous polymer dispersions containing colorants
11/10/2009	CA2300092C Anionic alkoxylate surfactant
11/05/2009	WO2009134856A2 Pharmaceutical gallium compositions and methods
11/05/2009	WO2009134594A1 Optical films comprising fluorenol (meth)acrylate monomer
11/05/2009	WO2009134147A1 Lipid compositions containing derivatives of epa and dha an their use thereof
11/05/2009	WO2009133846A1 Method for producing fatty acid alkyl ester and catalyst for production of fatty acid alkyl ester
11/05/2009	WO2009132526A1 An optically active pyrethroid compound and preparation process and use thereof
11/05/2009	US20090275752 Novel Process for Statins and its Pharmaceutically Acceptable Salts Thereof
11/05/2009	US20090275646 Therapeutic compounds
11/05/2009	US20090272295 Coating Materials Consisting of Low- or Medium-Molecular Organic Compounds
11/05/2009	CA2722571A1 Pharmaceutical gallium compositions and methods
11/04/2009	EP2113499A1 Use of metal salts of trifuoromethane sulphonic acid as esterification catalyst and/or transesterification catalyst
11/03/2009	US7612227 Reacting 3-methyl-2-buten-1-ol with acetic anhydride in the presence of an inorganic base catalyst, preferably potassium acetate; purifying by contact with sodium or potassium bisulfite or bicarbonate; environmentally friendly, cost efficient; raw material for pharmaceuticals and agricultural chemicals
11/03/2009	US7611822 Positive resist composition used for semiconductor microfabrication employing a lithography process contains an acid generator comprising a compound generating an acid by irradiation and a monomer having a bulky and acid-labile group
11/03/2009	US7611725 Additives and products including oligoesters
11/03/2009	CA2427579C Ortho substituted chiral phosphines and phosphinites and their use in asymmetric catalytic reactions
10/2009
10/29/2009	WO2009132093A2 Substituted arylcyclopentenes as therapeutic agents
10/29/2009	WO2009131977A1 Therapeutic compounds
10/29/2009	WO2009130211A1 Process for preparing unsaturated carboxylic esters
10/29/2009	WO2009099948A3 Efficient coalescing agents
10/29/2009	WO2008106334A3 Flame retarded styrenic polymer foams and foam precursors
10/29/2009	US20090270498 Lipoxin Compounds and Their use in Treating Cell Proliferative Disorders
10/29/2009	US20090270396 Therapeutic compounds
10/29/2009	US20090270385 useful in treating vision defects, inflammatory bowel disease, alopecia, the stimulation of hair growth and the stimulation of the conversion of vellus hair to terminal hair
10/29/2009	US20090269698 Compound, positive resist composition and method for formation of resist pattern
10/29/2009	US20090269294 Fragrance Precursor
10/29/2009	US20090266981 Internal standard material, resin composition, and measurement method
10/29/2009	CA2731279A1 Therapeutic compounds
10/29/2009	CA2722403A1 Substituted arylcyclopentenes as therapeutic agents
10/28/2009	EP2112135A2 E2, E4,Z8-undecatrienoic acid and ester and carboxamide derivatives thereof, organoleptic uses thereof and processes for preparing same
10/28/2009	EP2112134A1 Carboxylic acids and derivatives thereof and pharmaceutical compositions containing them
10/28/2009	EP2111389A1 Method for the production of substituted 2-aryl malonic acid esters
10/28/2009	EP2111387A1 New method for preparing unsaturated fatty hydroxy-acids
10/28/2009	CN101568559A Polymerizable compounds and polymerizable compositions
10/28/2009	CN101568515A Resin composition suitable for (re) lining of tubes, tanks and vessels
10/28/2009	CN101565435A P-chiral phospholanes and phosphocyclic compounds and their use in asymmetric catalytic reactions
10/28/2009	CN101565374A Method for depolymerizing waste polyester
10/28/2009	CN101565373A Method for preparing conjugated linoleic acid ethyl ester
10/28/2009	CN101565372A Preparation process of 3,3-dimethyl-4-pentenoic acid methyl ester
10/28/2009	CN101565371A Method for synthesizing asymmetrical diacylglycerol with benzyl protection
10/28/2009	CN101565370A Method for preparing xyl acetate
10/28/2009	CN100554242C Process for industrial separation of by-product alcohols
10/28/2009	CN100554241C Process for industrial separation of by-product alcohols
10/28/2009	CN100554240C Industrial preparation process for aromatic carbonate
10/28/2009	CN100554239C Industrial process for producing aromatic carbonate
10/28/2009	CN100554238C Apparatus for producing hydroxyalkyl (meth) acrylate and process for producing the same
10/28/2009	CN100554233C Process for producing alpha-oxocarbonyl compound
10/27/2009	US7608639 Such as 3-{4-[3-(4-Chloro-2- phenoxy-phenoxy)- phenoxy]-2-methyl- phenyl}-propionic acid; peroxisome proliferator activated receptor (PPAR); syndrome X, type II diabetes, hyperglycemia, hyperlipidemia, obesity, coagaulopathy, hypertension, arteriosclerosis
10/27/2009	US7608254 attractants comprising 2,9 diacetoxyundecane, 2,10-diacetoxyundecane and 2-acetoxyundecane, as racemic mixtures or stereoisomers, used for monitoring and/or disrupting mating of insects on vegetables
10/27/2009	CA2527698C Method for producing an aromatic carbonate
10/27/2009	CA2365204C Lipoxin compounds and their use
10/27/2009	CA2344505C Polyisocyanate compositions
10/22/2009	WO2009127560A1 Intermediates for the preparation of pregabalin and process for their preparation
10/22/2009	WO2009127352A1 PROCESS FOR PURIFYING AN α-KETO ESTER
10/22/2009	US20090264672 Methods of making organic compounds by metathesis
10/22/2009	US20090264671 Method for Producing Biodiesel Using Supercritical Alcohols
10/22/2009	US20090264657 Stabilization of body-care and household products against degradation by uv radiation using merocyanine derivatives
10/22/2009	US20090264654 Process for the preparation of pyrimidine compounds
10/22/2009	US20090264568 Method for producing fluorine-containing polymer, aqueous dispersion of fluorine-containing polymer, 2-acyloxycarboxylic acid derivative, and surface active agent
10/22/2009	US20090263726 Anode and method of manufacturing same, secondary battery and method of manufacturing same, and sulfone compound
10/22/2009	US20090263552 Organic Compounds and Methods
10/22/2009	US20090263492 Diagnostic Methods and Genetic Markers for Alzheimer Disease
10/22/2009	CA2717241A1 Process for purifying an .alpha.-keto ester
10/21/2009	EP2110372A1 Intermediates for the preparation of Pregabalin and process for their preparation
10/21/2009	EP1534427B1 An adamantyl catalyst system
10/21/2009	EP1363980B1 Luminescent polymers
10/21/2009	CN101563395A Polyimide, diamine compound and method for producing the same
10/21/2009	CN101563316A Process for the preparation and isolation of the individual stereoisomers of 1-amino, 3-substituted phenylcyclopentane carboxylates
10/21/2009	CN101563315A Ring opening cross-metathesis reaction of cyclic olefins with seed oils and the like
10/21/2009	CN101560155A Method for purifying cynarin in artichoke
10/21/2009	CN101560154A 6,6,6-trifluoromethyl-5-carbonyl methyl hexanoate, 2-trifluoromethyl-3-methyl indole propionate and synthesis method thereof
10/21/2009	CN101560153A 7,7,7-trifluoromethyl-6-carbonyl methyl heptanoate, 5-fluoro-2-trifluoromethyl-3-methyl indole butyrate and synthesis method thereof
10/21/2009	CN101560152A Method for synthesizing propionate
10/21/2009	CN101560151A Process for continuously generating methyl acetate by reactive distillation taking ionic liquid as catalyst
10/21/2009	CN101559385A Solid borne ionic liquid Cu salt catalyst as well as preparation method thereof and application in synthesis of dimethyl carbonate
10/21/2009	CN101559370A Cu-Cr series ethyl acetate catalyst added with modified additive and manufacturing method thereof
10/21/2009	CN101559359A Solid base catalyst used for preparing biodiesel by ester interchange and preparation method thereof
10/21/2009	CN100551898C 4-hepten-2-yl salicylate and its use as fragrance ingredient
10/21/2009	CN100551897C Method for refining and purifying long alkyl chain methacrylates
10/21/2009	CN100551531C Catalyst for ethanol gas phase oxidation for carbonyl for synthesizing diethyl carbonate and preparation method thereof
10/21/2009	CN100551505C Separation film for separating methanol/methyl-carbonate azotrope and its preparation method
10/20/2009	US7605288 2,5-(Aminocarbonylalkylene-(3,5-dihydroxy,6-halo-1,2-phenylene)-carbonyloxyalkylene)-)-p-quinone; chimera, mimetics of radicicol and geldanamycin; anticarcinogenic agents; antitumor agents; decreased toxicity; increased solubility and selectivity; enzyme inhibitors
10/20/2009	US7605286 Reacting with an acetal type protecting group such as methoxymethyl group, 2-(R-oxymethoxy-),3-haloprop-1-ene (R is phenyl or acyclic); stability; deprotecting under mild acidic conditions;industrial application; fungicides, viricides, HIV; antilipemic agents; obesity
10/20/2009	US7605285 Method and device for manufacturing dimethyl carbonate
10/20/2009	US7605181 Method for the treatment of metabolic disorders
10/20/2009	US7605179 administering vitamin k derivatives for prophylaxis of neurodegenerative diseases associated with protein aggregation or neurofibrillary tangles
10/20/2009	US7605178 Therapeutic compounds
10/20/2009	US7605166 Synergistic mixture of methotrexate and integrin antigen or antibody
10/20/2009	US7605111 Herbicides
10/20/2009	CA2585898C Use of (2s,3s,5s)-5-(n-(n-((n-methyl-n-((2-isopropyl-4-thaizolyl)methyl)amino)-carbonyl)valinyl)amino)-2-(n-((5-thiazolyl)methoxycarbonyl)amino)-1,6-diphenyl-3-hydroxyhexane in combination with another protease inhibitor for treating hiv infection
10/20/2009	CA2316141C Process for production of fatty acid methyl esters from fatty acid triglycerides
10/15/2009	WO2009125713A1 Method for producing of 2-alkyl-2-cycloalken-1-one

1 ... 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 ... 548